Noticias de BIIB

Noticias del mercado

Últimas noticias sobre BIIB — 229 novedades recientes. Análisis, balances, opiniones y cobertura de prensa.

Ticker: BIIB ✕ 229 resultados
20/04/2026 BIIB_US — ChartMill
TJ Biopharma Enters into Agreement with Biogen for Felzartamab Assets in the Greater China Region
20/04/2026 BIIB_US — DirectorsTalk Interviews ES ← EN
Análisis de acciones de Biogen Inc. (BIIB): navegando por un potencial alcista del 17% en medio de los desafíos del mercado

Biogen Inc. (BIIB) Stock Analysis: Navigating a 17% Potential Upside Amidst Market Challenges

20/04/2026 BIIB_US — Yahoo Finance
Biogen Earnings Preview: What to Expect
20/04/2026 BIIB_US — Stock Titan
Biogen pays $100M to take full global control of felzartamab
20/04/2026 BIIB_US — Yahoo Finance
Biogen Enters into Agreement with TJ Biopharma for Felzartamab Assets in the Greater China Region
20/04/2026 BIIB_US — Via Ritzau
Biogen Inc.
20/04/2026 BIIB_US — Biogen
Biogen Enters into Agreement with TJ Biopharma for Felzartamab Assets in the Greater China Region
20/04/2026 BIIB_US — Reuters
Biogen buys China rights to immune disease drug in up to $850 million deal with TJ Biopharma
20/04/2026 BIIB_US — Seeking Alpha
Biogen to buy China rights to immune disease drug for up to $850M
20/04/2026 BIIB_US — MarketBeat
Zurcher Kantonalbank Zurich Cantonalbank Buys 104,038 Shares of Biogen Inc. $BIIB
20/04/2026 BIIB_US — GuruFocus
Biogen Inc (BIIB) Shares Surge 3.4% -- What GF Score of 72 Tells Investors
19/04/2026 BIIB_US — MarketBeat
Biogen Inc. $BIIB Shares Acquired by KBC Group NV
19/04/2026 BIIB_US — MarketBeat
GF Fund Management CO. LTD. Sells 29,529 Shares of Biogen Inc. $BIIB
18/04/2026 BIIB_US — Kalkine Media
Biogen Inc. (NASDAQ:BIIB) Rating Balance Draws Nasdaq Composite Attention
18/04/2026 BIIB_US — MarketBeat
Biogen Inc. (NASDAQ:BIIB) Given Consensus Recommendation of "Hold" by Brokerages
17/04/2026 BIIB_US — Yahoo Finance
Zacks.com featured highlights include Biogen, TE Connectivity and ZTO Express (Cayman)
17/04/2026 BIIB_US — The Business Journals
Biogen CEO: China will match U.S. drug innovation in five to 10 years
16/04/2026 BIIB_US — The Business Journals
'There's a lot of momentum': Biogen acquisition translates into West Coast hub with immunology focus
16/04/2026 BIIB_US — MarketWatch
Biogen Inc. stock underperforms Thursday when compared to competitors
15/04/2026 BIIB_US — MarketBeat
Sumitomo Mitsui Trust Group Inc. Lowers Holdings in Biogen Inc. $BIIB

Página 7 de 12

keyboard_arrow_up